Table 1.
Patients’ characteristics and prebiopsy status comparison between the two groups (n = 94)
| Variables | Total | Group 1 (n = 47) | Group 2 (n = 47) | p value |
|---|---|---|---|---|
| Age (years) | 70.6 ± 8.8 | 70.7 ± 8.6 | 70.4 ± 9.1 | 0.862 |
| Body mass index (kg/m2) | 24.8 ± 3.3 | 24.3 ± 3.3 | 25.4 ± 3.2 | 0.127 |
| Hypertension (%) | 41 (43.6) | 20 (42.6) | 21 (44.7) | 0.835 |
| Diabetes mellitus (%) | 22 (23.4) | 9 (19.1) | 13 (27.7) | 0.330 |
| Cancer history (%) | 23 (24.5) | 10 (21.3) | 13 (27.7) | 0.472 |
| Biopsy history (%) | 22 (23.4) | 8 (17.0) | 14 (29.8) | 0.144 |
| Prostate-specific antigen (ng/mL) | 14.6 ± 26.0 | 12.2 ± 16.8 | 17.1 ± 32.7 | 0.377 |
| Testosterone (ng/mL) | 3.2 ± 1.1 | 3.2 ± 1.2 | 3.1 ± 1.1 | 0.679 |
| Total IPSS score | 13.4 ± 8.1 | 14.6 ± 6.9 | 12.3 ± 9.0 | 0.185 |
| Voiding symptom | 7.8 ± 5.4 | 8.4 ± 4.5 | 7.2 ± 6.2 | 0.274 |
| Storage symptom | 5.7 ± 3.3 | 6.1 ± 3.1 | 5.2 ± 3.4 | 0.149 |
| Maximal flow rate (mL/sec) | 14.5 ± 6.9 | 14.9 ± 6.9 | 14.0 ± 7.0 | 0.519 |
| Postvoid residual urine (mL) | 54.9 ± 62.5 | 51.8 ± 58.4 | 58.1 ± 66.8 | 0.631 |
| IIEF-5 score | 10.2 ± 7.3 | 9.4 ± 7.5 | 11.0 ± 7.1 | 0.294 |
| AMS score | 38.1 ± 12.1 | 38.8 ± 13.6 | 37.4 ± 10.5 | 0.565 |
| Objective parameters | ||||
| Systolic BP (mmHg) | 121.8 ± 13.7 | 122.5 ± 11.7 | 121.1 ± 15.6 | 0.612 |
| Diastolic BP (mmHg) | 74.3 ± 9.8 | 75.5 ± 8.9 | 73.1 ± 10.7 | 0.234 |
| Heart rate (beats/min) | 69.5 ± 7.6 | 69.9 ± 7.7 | 69.1 ± 7.5 | 0.636 |
| Respiratory rate (breaths/min) | 19.9 ± 0.6 | 19.9 ± 0.6 | 19.9 ± 0.6 | 1.000 |
| Arterial oxygen saturation (%) | 96.4 ± 1.4 | 96.4 ± 1.4 | 96.4 ± 1.4 | 0.885 |
| Subjective parameters | ||||
| STAI-state score | 46.0 ± 6.2 | 45.9 ± 7.5 | 46.2 ± 4.7 | 0.843 |
| STAI-trait score | 42.8 ± 7.2 | 42.5 ± 8.2 | 43.1 ± 6.2 | 0.681 |
| Prostate volume | 41.2 ± 19.8 | 42.4 ± 22.0 | 40.0 ± 17.5 | 0.556 |
| Postbiopsy Pca diagnosis (%) | 52 (55.3%) | 24 (51.1) | 28 (55.3) | 0.407 |
IPSS, international prostate symptom score; IIEF, international index of erectile function; AMS, aging males' symptoms; BP, blood pressure; STAI, state-trait anxiety inventory; Pca, prostate cancer.